Generics 110

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cefotaxime manufacturers

110 products found

Filters

110 products found

cefotaxime

Vials, injection 500 mg, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Greece , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela , Vietnam
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

cefotaxime

Solution for injection 500 mg, 1 g

Dossier type
EU CTD
Dossier status
Outdated
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

cefotaxime

Powder for solution for injection 500 mg, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

cefotaxime

Vials, injection 0.5 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq
Available for
Licensing with supply, Distribution only
Manufacturer #16255
The company is a 100% Greek pharmaceutical company whose major activities are the creation and trading of branded generic pharmaceutical products while maintaining a high level of patient respect and devotion. It is the holder of more than 70 marketing authorizations for pharmaceutical products and the launcher of more than 46 of them.

Manufacturer usually replies in 8 days

cefotaxime

Powder and solvent for solution for injection 500mg, 1g, 2g - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Technology transfer
Comments
Reference product: Claforan® Supply temporally restricted, looking for CMO. Technology Transfer available.
Manufacturer #10142
They have more than 40 generic drug products available for license to our global partners. The EU-CTD format is used for all product dossiers. All generic drug products are manufactured in the European Union (EU) and distributed globally to brand partners. Concentrate on delivering high-quality products on time and at a reasonable price.

Manufacturer usually replies in 9 days

cefotaxime

Vials, injection 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11676
It is the fastest-growing pharmaceutical manufacturer operating in South-East Europe. The company is focused on making available contemporary therapeutical solutions in the local, regional and European markets under GMP. The company has expertise in fast market penetration is proven by the results achieved for their partners.

Manufacturer usually replies in 6 days

cefotaxime

Solution for injection 250 mg. 500mg. 1g. 2g.

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

cefotaxime

Solution for injection 1g, 2g - 10ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

cefotaxime

Powder and solvent for solution for injection 1 g/4 ml, 1 g/10 ml, 1 g/3.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

cefotaxime

Powder for solution for injection 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

cefotaxime

Vials, injection 500 mg, 1 g, 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

cefotaxime

Powder for solution for injection/infusion 1g, 2g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16200
It is a medium-sized international pharmaceutical firm with headquarters, development, and manufacturing in Europe with a corporate history spanning more than 65 years. The mission statement is entirely focused on providing high-quality medicines to clients promptly. Our continued success is built on qualified employees, cutting-edge production facilities and processes, as well as an appreciative and performance-enhancing corporate culture.

Manufacturer usually replies in 13 days

cefotaxime

Powder for solution for injection/infusion 0.5 g, 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #354

cefotaxime

Powder for solution for injection/infusion 1 g

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Iraq , Serbia , Vietnam
Comments
Dossier availability depending on country legislation
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

cefotaxime

Injection 1 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30077

Manufacturer usually replies in nan days

cefotaxime

Vials, lyophilized injection 1g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
MAs for sale
Latvia , Azerbaijan , Belarus , Georgia , Kyrgyzstan , Moldova , Tajikistan , Ukraine , Uzbekistan
Manufacturer #16118
The pharmaceutical plant follows the European standard throughout the plant. The core belief of the plant is to make sure that the customer receives the best pharmaceutical benefits as well as the intended patient care services.

Manufacturer usually replies in 7 days

cefotaxime

Ampoules, injection 500 mg, 1 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

cefotaxime

Injection 250 mg, 500 mg, 1 g, 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

cefotaxime

Injection 500 mg, 1000 mg, 2000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
PICS
Manufacturer #21831

Manufacturer usually replies in 1 days

cefotaxime

Injection 250 mg, 500 mg, 1000 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

Want to view all 110 products? Create your free account today!

Cefotaxime

Cefotaxime is an antibiotic used in the treatment of a number of bacterial infections. Specifically in the treatment of joint infections, pelvic inflammatory diseases, meningitis, pneumonia, urinary tract infections, sepsis, gonorrhea, and cellulitis. It is specifically prescribed in the treatment of Lower respiratory tract infections like pneumonia, which is most commonly caused, by S. pneumonia or genitourinary system infections - urinary tract infections like E. coli, S. epidermidis, and P. mirabilis and cervical or urethral gonorrhea. It is also used in the treatment of Gynecologic infections like pelvic inflammatory disease, endometritis, and pelvic cellulitis and sepsis-like secondary to Streptococcus spp, S. aureus, E. coli, and Klebsiella spp. It is also used in the treatment of Intra-abdominal infections like peritonitis, in the treatment of bone and joint infections caused by S. aureus, Streptococcus spp and CNS infections like meningitis or ventriculitis secondary to N. meningitides, H. influenzae, S. pneumonia. Cefotaxime is traded under the brand name Claforan among others. Takeda chemical industries ltd discovered it in 1976, and Cefotaxime came into commercial use in 1980. It record on efficacy has earned it a place on the World Health Organization's List of Essential Medicines. It is sold as a generic medication.

Dosage Forms & Strengths

Cefotaxime is given either by injection into a vein or muscle. Its injectable solution is sold in 20mg/mL, 40mg/mL and the powder for injection is for 500mg is sold in 1g, 2g, 10g concentrations. In the treatment of Gonococcal Urethritis or Cervicitis, the standard recommended dose is 0.5 g IM once, and in the treatment of Rectal Gonorrhea, the men are recommended a dose of 1 g IM once and women are prescribed a dose 0.5 g IM once. In the treatment of Infections Caused by Susceptible Organisms of the Uncomplicated types, the standard recommended dose is 1 g IV or IM administered every 12 hours and in the treatment of moderate to severe cases, the dose is 1-2 g IV or IM every 8 hours. In the treatment of More serious bloodstream infections like septicemia the prescribed dose is 2 g IV given every 6-8 hours and in the Life-threatening case, 2 g IV every 4 hours but the maximum daily dose cannot exceed 12 g per day. While preparing Preparation for Surgery, in the treatment of Prophylaxis of surgical infection, the recommended dose is 1 g IM/IV once 30-90 minutes before the start of the procedure.

The price of Cefotaxime

In the USA, consumers pay $56 for a Cefotaxime injectable powder for injection 1 g is around for a supply of 25 powder for injection and Cefotaxime Sodium Injection of 4ml, cost around $1.05 in India.

How does it work?

Cefotaxime is a β-lactam antibiotic, meaning it is related to structural components of the drug molecule itself. β-lactams work by inhibiting bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins. The inhibition leads to the final trans-peptidation of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria lyse due to ongoing activity eventually in the cell wall autolytic enzymes in the absence of cell wall assembly. β-lactams are considered to be bactericidal.

Finding Cefotaxime Manufacturers and Cefotaxime Suppliers

One of the fastest and easiest ways to find Cefotaxime manufacturers and Cefotaxime suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Cefotaxime can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Cefotaxime to work with. You can fine-tune your search results using various filters too, letting you search for Cefotaxime from specific countries, for example.